Streamlining B2B Cross Border Payments and Trade Finance in Pharma

Settle payments instantly. Discount your invoice receivables at best rates.

White Paper
MVP
Lightbox

Token Sale Ends In

Buy PharmX Tokens

Tokensale Stages

Private Pre-Sale
ends by April 30, 2024

1 PharmX token at 0.01 USD

10% bonus

50,000,000 PharmX tokens on SALE

(raising up to $0.5 million)

Pre-Sale
ends by May 30, 2024

1 PharmX at 0.02 USD

5% bonus

100,000,000 PharmX tokens on SALE

(raising up to $2 million)

Crowd Sale
ends by June 30, 2024

1 PharmX at 0.1 USD

1% bonus

150,000,000 PharmX tokens on SALE

(raising up to $15 million)

What is PharmX Token

Watch video

About PharmX

PharmX facilitates seamless cross-border settlements within the pharmaceutical industry, offering B2B companies in Africa and LATAM an efficient solution to mitigate the costs and time associated with international transactions, and access to best rates to discount their invoice receivables.

Importers can leverage PharmX tokens to instantly pay for the import of essential medications into Africa and LATAM. Exporters on the other hand receive payment instantly. 

 

For IMPORTERS:

  • FASTER settlements
  • REDUCED fees
  • IMPROVED transparency

 

For EXPORTERS:

  • RECEIVE payments faster
  • BEST RATES to discount invoice receivables
  • IMPROVED cashflows

Token Structure

60%
Token sale program
9%
Reserved Funding
15%
Founders and Team
4%
Advisors
7%
Eco System Development
6%
Marketing and Bounty
Cost of 1 token PharmX: Varies by the stage of the Token Sale
Term of token sale: 90 days with the possibility of an automatic early completion in pursuing the final goals of the token sale
Expanded goals after start of token sale: Impossible
Technical limitation of tokens: 500,000,000 (500M Tokens)
Adjustable emission: All unsold and unallocated tokens will be destroyed and additional release оf tokens will not be possible
Secured ways to purchase tokens: Bitcoin (ВТC), Ethereum (ETH), USDT payments
Hardcap: $17,500,000 ($17.5 Million)

Roadmap

June 2023
Research and validation of problem statement
Jan 2024
Cross border payment infrastructure design
Dec 2024
PharmX payments Go Live
Sep 2023
Interaction of various stakeholders in South Pharma
Jun 2024
TestNet of PharmX payments infrastructure

Soft-cap Budget Allocation

  • 27% Product Development

  • 39% Marketing, sales, merchant acquisition & partnerships

  • 12% Operations

  • 6% Legal

  • 16% Management